Stay updated on Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.

Latest updates to the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 in the study documents section; this is a metadata update that does not alter participant criteria, endpoints, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 in the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedIntroduces a new 'Show glossary' option and includes minor label/copy tweaks (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), plus a footer update to 'Revision: v3.4.0' replacing the previous version.SummaryDifference0.1%

- Check42 days agoChange DetectedFooter now displays Revision: v3.3.4; the previous Revision: v3.3.3 is no longer displayed.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section with state listings (Arizona, California, Hawaii, Indiana, Kentucky, Maryland, Massachusetts, Minnesota, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Washington) and updated the revision to v3.3.3. Some state location subsections were removed, and the HHS Vulnerability Disclosure notice was also removed.SummaryDifference0.8%

- Check92 days agoChange DetectedRevision: v3.3.2 added; Revision: v3.2.0 deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Padsevonil Adjunct in Drug-resistant Epilepsy Clinical Trial page.